RT Journal Article
T1 [Recommendations for vaccination against ROTAvirus in PREMature newborns (ROTAPREM)].
T2 Recomendaciones para la vacunación frente al ROTAvirus de los recién nacidos PREMaturos (ROTAPREM).
A1 Álvarez Aldeán, Javier
A1 Ares Segura, Susana
A1 Díaz González, Celia
A1 Montesdeoca Melián, Abián
A1 García Sánchez, Rubén
A1 Boix Alonso, Héctor
A1 Moreno-Pérez, David
A1 en representación de la Sociedad Española de Neonatología (SENeo) y del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP), 
K1 Acute gastroenteritis
K1 Cobertura
K1 Coverage
K1 Gastroenteritis aguda
K1 Immunisation
K1 Premature
K1 Prematuro
K1 Rotavirus
K1 Vacunación
AB Rotavirus (RV) is the leading cause of severe acute gastroenteritis in infants worldwide. Most children are infected by RV by the age of 5years, and especially in the first 2years. Two oral attenuated vaccines against RV are licensed in industrialised countries, which have proven to be safe and effective against the disease. The main objective of these vaccines has been to reproduce the natural history of infection and protect against severe disease in the first months of life. Preterm infants are at higher risk of severe RV infection compared to full-term infants and infants with normal birth weight. Data collected on RV vaccination in preterm infants demonstrated that RV vaccines are effective and safe, compared with full-term infants, with a marginal risk of horizontal viral transmission and dissemination when vaccination is performed during hospitalisation. Preterm infants frequently require admission to hospital after the beginning of the 12th week of life, which suggests that they should receive RV vaccines during admission according to the official immunisation schedule.
YR 2019
FD 2019-07-06
LK https://hdl.handle.net/10668/25082
UL https://hdl.handle.net/10668/25082
LA es
DS RISalud
RD Apr 11, 2025